Liu Z - Search Results

1

Potential synaptic plasticity-based Shenzhiling oral liquid for a SAD Mouse Model.

Wang Y, Wang P, Chen F, Lulu M, Huang S, Liu Z. Wang Y, et al. Among authors: liu z. Brain Behav. 2019 Sep;9(9):e01385. doi: 10.1002/brb3.1385. Epub 2019 Aug 20. Brain Behav. 2019. PMID: 31429527 Free PMC article.

2

GAPT regulates cholinergic dysfunction and oxidative stress in the brains of learning and memory impairment mice induced by scopolamine.

Liu Z, Qin G, Mana L, Dong Y, Huang S, Wang Y, Wu Y, Shi J, Tian J, Wang P. Liu Z, et al. Brain Behav. 2020 May;10(5):e01602. doi: 10.1002/brb3.1602. Epub 2020 Mar 15. Brain Behav. 2020. PMID: 32174034 Free PMC article.

3

Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury.

Liu Z, Wang P, Lu S, Guo R, Gao W, Tong H, Yin Y, Han X, Liu T, Chen X, Zhu MX, Yang Z. Liu Z, et al. Among authors: liu t. Cell Calcium. 2020 Apr 28;88:102198. doi: 10.1016/j.ceca.2020.102198. Online ahead of print. Cell Calcium. 2020. PMID: 32388008

4

Shenzhiling Oral Liquid Protects STZ-Injured Oligodendrocyte through PI3K/Akt-mTOR Pathway.

Liu Z, Qin G, Mana L, Huang S, Wang Y, Wang P. Liu Z, et al. Evid Based Complement Alternat Med. 2020 Jul 24;2020:4527283. doi: 10.1155/2020/4527283. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32774416 Free PMC article.

5

Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.

Zheng M, Liu Z, Mana L, Qin G, Huang S, Gong Z, Tian M, He Y, Wang P. Zheng M, et al. Among authors: liu z. J Ethnopharmacol. 2021 Oct 5;278:114264. doi: 10.1016/j.jep.2021.114264. Epub 2021 Jun 1. J Ethnopharmacol. 2021. PMID: 34082015

6

Shenzhiling oral solution promotes myelin repair through PI3K/Akt-mTOR pathway in STZ-induced SAD mice.

Qin G, Wang Y, Liu Z, Mana L, Huang S, Wang P. Qin G, et al. Among authors: liu z. 3 Biotech. 2021 Jul;11(7):361. doi: 10.1007/s13205-021-02900-x. Epub 2021 Jul 1. 3 Biotech. 2021. PMID: 34295606 Free PMC article.

7

Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro.

Qin G, Dong Y, Liu Z, Gong Z, Gao C, Zheng M, Tian M, He Y, Zhong L, Wang P. Qin G, et al. Among authors: liu z. Chin Med. 2021 Dec 2;16(1):128. doi: 10.1186/s13020-021-00540-0. Chin Med. 2021. PMID: 34857022 Free PMC article.

8

Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro.

Qin G, Dong Y, Liu Z, Gong Z, Gao C, Zheng M, Tian M, He Y, Zhong L, Wang P. Qin G, et al. Among authors: liu z. Chin Med. 2021 Dec 31;16(1):144. doi: 10.1186/s13020-021-00551-x. Chin Med. 2021. PMID: 34972523 Free PMC article. No abstract available.

9

Revisiting the role of the complement system in intracerebral hemorrhage and therapeutic prospects.

Li Y, Tao C, An N, Liu H, Liu Z, Zhang H, Sun Y, Xing Y, Gao Y. Li Y, et al. Among authors: liu z, liu h. Int Immunopharmacol. 2023 Oct;123:110744. doi: 10.1016/j.intimp.2023.110744. Epub 2023 Aug 7. Int Immunopharmacol. 2023. PMID: 37552908 Review.

10

Pathological mechanisms and future therapeutic directions of thrombin in intracerebral hemorrhage: a systematic review.

Tao C, Li Y, An N, Liu H, Liu Z, Sun Y, Qian Y, Li N, Xing Y, Gao Y. Tao C, et al. Among authors: liu z, liu h. Front Pharmacol. 2024 Apr 18;15:1293428. doi: 10.3389/fphar.2024.1293428. eCollection 2024. Front Pharmacol. 2024. PMID: 38698822 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,788 results

Search Page

Filters